Proteomic signatures of human oral epithelial cells in HIV-infected subjects

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Yohannes, Elizabeth ^a   Ghosh, Santosh K ^b   Jiang, Bin ^b   McCormick, Thomas S ^a   Weinberg, Aaron ^b   Hill, Edward ^b   Faddoul, Faddy ^b   Chance, Mark R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 90; HEAT SHOCK TRANSCRIPTION FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN DISULFIDE ISOMERASE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL ASSAY; CELL STRESS; CONTROLLED STUDY; DETOXIFICATION; DOWN REGULATION; FEMALE; FUNCTIONAL PROTEOMICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INNATE IMMUNITY; MALE; MOUTH MUCOSA; OXIDATION REDUCTION STATE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; VIRUS LOAD; WESTERN BLOTTING; CASE CONTROL STUDY; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; EPITHELIUM CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MOUTH; PATHOGENICITY; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; PROTEOMICS; VIROLOGY;

BACTERIA (MICROORGANISMS);

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELLS, CULTURED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPITHELIAL CELLS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOUTH; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; PROTEOMICS; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 81155137314     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027816     Document Type: Article

References (68)

1. Greenspan D, Greenspan JS, (1996) HIV-related oral disease. Lancet 348: 729-733.
2. Leao JC, Ribeiro CM, Carvalho AA, Frezzini C, Porter S, (2009) Oral complications of HIV disease. Clinics (Sao Paulo) 64: 459-470.
3. Nicolatou-Galitis O, Velegraki A, Paikos S, Economopoulou P, Stefaniotis T, et al. (2004) Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study. Oral Dis 10: 145-150.
4. Bedimo R, (2008) Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era. Curr HIV/AIDS Rep 5: 140-149.
5. Baumgarth N, Szubin R, Dolganov GM, Watnik MR, Greenspan D, et al. (2004) Highly tissue substructure-specific effects of human papilloma virus in mucosa of HIV-infected patients revealed by laser-dissection microscopy-assisted gene expression profiling. Am J Pathol 165: 707-718.
6. Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS, (2001) Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 357: 1411-1412.
7. Greenspan D, Gange SJ, Phelan JA, Navazesh M, Alves ME, et al. (2004) Incidence of oral lesions in HIV-1-infected women: reduction with HAART. J Dent Res 83: 145-150.
8. Hodgson TA, Greenspan D, Greenspan JS, (2006) Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res 19: 57-62.
9. Cauda R, Tacconelli E, Tumbarello M, Morace G, De Bernardis F, et al. (1999) Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. J Acquir Immune Defic Syndr 21: 20-25.
10. De Bernardis F, Tacconelli E, Mondello F, Cataldo A, Arancia S, et al. (2004) Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility. FEMS Immunol Med Microbiol 41: 27-34.
11. Volter C, He Y, Delius H, Roy-Burman A, Greenspan JS, et al. (1996) Novel HPV types present in oral papillomatous lesions from patients with HIV infection. Int J Cancer 66: 453-456.
12. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA, (2009) Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 101: 1120-1130.
13. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM, (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370: 59-67.
14. Besson C, Goubar A, Gabarre J, Rozenbaum W, Pialoux G, et al. (2001) Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98: 2339-2344.
15. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, et al. (2005) Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97: 577-586.
16. Clifford GM, Goncalves MA, Franceschi S, (2006) Human papillomavirus types among women infected with HIV: a meta-analysis. Aids 20: 2337-2344.
17. Carter MM, Torres SM, Cook DL Jr, McCash CL, Yu M, et al. (2007) Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells. Environ Mol Mutagen 48: 239-247.
18. Torres SM, Walker DM, Carter MM, Cook DL Jr, McCash CL, et al. (2007) Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations. Environ Mol Mutagen 48: 224-238.
19. Nibbe RK, Markowitz S, Myeroff L, Ewing R, Chance MR, (2009) Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer. Mol Cell Proteomics 8: 827-845.
20. Yohannes E, Chang J, Christ GJ, Davies KP, Chance MR, (2008) Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction. Mol Cell Proteomics 7: 1270-1285.
21. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037.
22. Kulkarni H, Okulicz JF, Grandits G, Crum-Cianflone NF, Landrum ML, et al. Early Post-Seroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1-Postive Subjects Receiving Antiretroviral Therapy. J Acquir Immune Defic Syndr.
23. Shoeman RL, Honer B, Stoller TJ, Kesselmeier C, Miedel MC, et al. (1990) Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein. Proc Natl Acad Sci U S A 87: 6336-6340.
24. Singh B, Arlinghaus RB, (1989) Vimentin phosphorylation by p37mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cells. Virology 173: 144-156.
25. Paul S, Gharami K, Das S, Sarkar PK, (1999) Thyroid hormone-induced maturation of astrocytes is associated with the expression of new variants of vimentin and their phosphorylation. J Neurochem 73: 1964-1972.
26. Muller K, Dulku S, Hardwick SJ, Skepper JN, Mitchinson MJ, (2001) Changes in vimentin in human macrophages during apoptosis induced by oxidised low density lipoprotein. Atherosclerosis 156: 133-144.
27. Sarge KD, Murphy SP, Morimoto RI, (1993) Activation of heat shock gene transcription by heat shock factor 1 involves oligomerization, acquisition of DNA-binding activity, and nuclear localization and can occur in the absence of stress. Mol Cell Biol 13: 1392-1407.
28. Holmberg CI, Hietakangas V, Mikhailov A, Rantanen JO, Kallio M, et al. (2001) Phosphorylation of serine 230 promotes inducible transcriptional activity of heat shock factor 1. EMBO J 20: 3800-3810.
29. Zou J, Guo Y, Guettouche T, Smith DF, Voellmy R, (1998) Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 94: 471-480.
30. Bharadwaj S, Ali A, Ovsenek N, (1999) Multiple components of the HSP90 chaperone complex function in regulation of heat shock factor 1 In vivo. Mol Cell Biol 19: 8033-8041.
31. Inouye S, Izu H, Takaki E, Suzuki H, Shirai M, et al. (2004) Impaired IgG production in mice deficient for heat shock transcription factor 1. J Biol Chem 279: 38701-38709.
32. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, et al. (1999) Regulation of JNK signaling by GSTp. EMBO J 18: 1321-1334.
33. Kim YJ, Lee WS, Ip C, Chae HZ, Park EM, et al. (2006) Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. Cancer Res 66: 7136-7142.
34. Shen HM, Liu ZG, (2006) JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med 40: 928-939.
35. Kyriakis JM, Avruch J, (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807-869.
36. Kins S, Kurosinski P, Nitsch RM, Gotz J, (2003) Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice. Am J Pathol 163: 833-843.
37. Fu W, Sanders-Beer BE, Katz KS, Maglott DR, Pruitt KD, et al. (2009) Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Res 37: D417-422.
38. Ptak RG, Fu W, Sanders-Beer BE, Dickerson JE, Pinney JW, et al. (2008) Cataloguing the HIV type 1 human protein interaction network. AIDS Res Hum Retroviruses 24: 1497-1502.
39. Chow YH, Yu D, Zhang JY, Xie Y, Wei OL, et al. (2002) gp120-Independent infection of CD4(-) epithelial cells and CD4(+) T-cells by HIV-1. J Acquir Immune Defic Syndr 30: 1-8.
40. Pang S, Yu D, An DS, Baldwin GC, Xie Y, et al. (2000) Human immunodeficiency virus Env-independent infection of human CD4(-) cells. J Virol 74: 10994-11000.
41. Liu X, Zha J, Chen H, Nishitani J, Camargo P, et al. (2003) Human immunodeficiency virus type 1 infection and replication in normal human oral keratinocytes. J Virol 77: 3470-3476.
42. Moir S, Chun TW, Fauci AS, Pathogenic mechanisms of HIV disease. Annu Rev Pathol 6: 223-248.
43. Challacombe SJ, Naglik JR, (2006) The effects of HIV infection on oral mucosal immunity. Adv Dent Res 19: 29-35.
44. Rawat P, Mitra D, Cellular heat shock factor 1 positively regulates human immunodeficiency virus-1 gene expression and replication by two distinct pathways. Nucleic Acids Res.
45. Kocsis J, Prohaszka Z, Biro A, Fust G, Banhegyi D, (2003) Elevated levels of antibodies against 70 kDa heat shock proteins in the sera of patients with HIV infection. J Med Virol 71: 480-482.
46. Nicchitta CV, (2003) Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity. Nat Rev Immunol 3: 427-432.
47. Henderson B, Allan E, Coates AR, (2006) Stress wars: the direct role of host and bacterial molecular chaperones in bacterial infection. Infect Immun 74: 3693-3706.
48. Kebba A, Stebbing J, Rowland S, Ingram R, Agaba J, et al. (2005) Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjects. J Leukoc Biol 78: 37-42.
49. Holaska JM, Black BE, Rastinejad F, Paschal BM, (2002) Ca2+-dependent nuclear export mediated by calreticulin. Mol Cell Biol 22: 6286-6297.
50. Hirata F, Hirata A, (1990) Biology of phospholipase inhibitory proteins. Adv Exp Med Biol 279: 211-218.
51. Miele L, (2003) New weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase. J Clin Invest 111: 19-21.
52. Sundaram M, Saghayam S, Priya B, Venkatesh KK, Balakrishnan P, et al. (2008) Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India. Int J Infect Dis 12: e61-66.
53. Muller F, Svardal AM, Nordoy I, Berge RK, Aukrust P, et al. (2000) Virological and immunological effects of antioxidant treatment in patients with HIV infection. Eur J Clin Invest 30: 905-914.
54. Gess B, Hofbauer KH, Wenger RH, Lohaus C, Meyer HE, et al. (2003) The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lalpha. Eur J Biochem 270: 2228-2235.
55. May D, Itin A, Gal O, Kalinski H, Feinstein E, et al. (2005) Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer. Oncogene 24: 1011-1020.
56. Li X, Feng J, Sun R, Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells. J Virol 85: 715-724.
57. Perluigi M, Giorgi A, Blarzino C, De Marco F, Foppoli C, et al. (2009) Proteomics analysis of protein expression and specific protein oxidation in human papillomavirus transformed keratinocytes upon UVB irradiation. J Cell Mol Med 13: 1809-1822.
58. Wang T, Arifoglu P, Ronai Z, Tew KD, (2001) Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 276: 20999-21003.
59. Tanaka T, Zhong J, Iqbal K, Trenkner E, Grundke-Iqbal I, (1998) The regulation of phosphorylation of tau in SY5Y neuroblastoma cells: the role of protein phosphatases. FEBS Lett 426: 248-254.
60. Chung H, Brautigan DL, (1999) Protein phosphatase 2A suppresses MAP kinase signalling and ectopic protein expression. Cell Signal 11: 575-580.
61. Zai A, Rudd MA, Scribner AW, Loscalzo J, (1999) Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest 103: 393-399.
62. Konig J, Baier M, Horling F, Kahmann U, Harris G, et al. (2002) The plant-specific function of 2-Cys peroxiredoxin-mediated detoxification of peroxides in the redox-hierarchy of photosynthetic electron flux. Proc Natl Acad Sci U S A 99: 5738-5743.
63. Honer B, Shoeman RL, Traub P, (1991) Human immunodeficiency virus type 1 protease microinjected into cultured human skin fibroblasts cleaves vimentin and affects cytoskeletal and nuclear architecture. J Cell Sci 100 (Pt 4): 799-807.
64. Joshi R, Tawfik A, Edeh N, McCloud V, Looney S, et al. (2010) Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2. PLoS One 5: e13974.
65. Ji JH, Jang YJ, (2009) Cellular effects of genotoxic stress and gene silencing of the checkpoint kinases in human oral cells. J Oral Pathol Med 38: 591-596.
66. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, et al. (2000) Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 68: 2907-2915.
67. Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA, (1998) Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun 66: 4222-4228.
68. Shevchenko A, Wilm M, Vorm O, Mann M, (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858.